Jeremy Whitley, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6325 Hospital Pkwy, Johns Creek, GA 30097 Phone: 678-474-7100 |
Dr. Arthur A Griffiths, MD Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 6325 Hospital Pkwy, Johns Creek, GA 30097 Phone: 678-474-7100 Fax: 678-474-7107 |
Lorenzo Jameson Camejo, Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 11340 Lakefield Dr Ste 200, Johns Creek, GA 30097 Phone: 678-523-8355 |
Richard G Dukes, MD Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 11705 Jones Bridge Rd, Suite A201, Johns Creek, GA 30005 Phone: 770-772-1830 Fax: 770-772-7238 |
Dr. Earl Alwin Grubbs, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 High Bridge Chase, Johns Creek, GA 30022 Phone: 770-740-9231 Fax: 770-569-4598 |
Uzair Ahmed Janjua, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 6325 Hospital Pkwy, Johns Creek, GA 30097 Phone: 678-474-7000 |
News Archive
StockPreacher.com announces an investment report featuring Imaging3 Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Dartmouth researchers, working with scientists at the University of Arizona and at the Department of Natural Resources in Sonora, Mexico, have published a study on the impact of arsenic exposure on DNA damage.
Hypoxic preconditioning has been shown to have protective effects against acute cerebral infarction. To investigate the protective mechanisms of hypoxic preconditioning in relation to its effects on angiogenesis, Prof. Xunming Ji and team from Xuanwu Hospital, Capital Medical University in China induced a photochemical model of cerebral infarction in an inbred line of mice (BALB/c) which were exposed to hypoxic preconditioning prior to model establishment.
Researchers from the University of Bristol, Oxford Brookes University and the University of California San Diego neatly demonstrated how the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits high affinity for nicotinic acetylcholine receptors (nAChRs), with significant implications for coronavirus disease (COVID-19) pathology and infectivity. Their findings are published on the bioRxiv* preprint server.
Sanofi US today announced that the U. S. District Court in Massachusetts granted the company a preliminary injunction against a Synvisc-One (hylan G-F 20) competitor product developed by Seikagaku Corporation.
› Verified 2 days ago